Loading
Latest filing: trade of 26 Aug 2026 for TME Pharma N.V., €170k. The register gives no publication date. Read the official filing
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of D.M. van den Ouden in TME Pharma N.V. We count 9 filings; the first trade dates from 19 September 2025 and the latest from 26 August 2026.
The open-market side counts 5 purchases for €60k alongside 3 sales for €384k. Netting one side against the other leaves €325k of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2026, the count stands at no purchases and 3 sales.
Half of the purchases are above €9,500 and half below.
Most recently, on 31 August 2026, the filings show an open-market sale worth €170k in TME Pharma N.V. The last insider purchase was made public on 30 September 2025, 383 days ago. These figures are compiled from regulatory filings published by AFM. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations